Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06598514 · ClinicalTrials.gov registry record · Phase 4
Chlorhexidine Lavage for Recurrent Urinary Tract Infection
A Phase 4 study of Urinary Tract Infections and Recurrent Urinary Tract Infection, sponsored by Oregon Health and Science University.
- Active
- Registry status
- Phase 4
- Development phase
- 136
- Enrollment target
- 1
- Study location
NCT06598514 is a Phase 4 study of Urinary Tract Infections and Recurrent Urinary Tract Infection that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 136 participants, below the 454-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06598514, a Phase 4 study of Urinary Tract Infections and Recurrent Urinary Tract Infection, is active but no longer recruiting, sponsored by Oregon Health and Science University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 136 participants
- Enrollment target
- 1
- Study location
Study Summary
A two-arm randomized control trial evaluating rates of urinary tract infection in post-menopausal women on vaginal estrogen with recurrent urinary tract infections.
Conditions Studied
Interventions
- DRUG Chlorhexidine
- DRUG Sterile Water
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2024-12-23 |
| Est. Completion | 2026-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06598514
The ClinicalTrials.gov registry entry for NCT06598514 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (70% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Chlorhexidine is the first listed.
NCT06598514 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06598514 about?
NCT06598514 is a clinical study titled "Chlorhexidine Lavage for Recurrent Urinary Tract Infection". A two-arm randomized control trial evaluating rates of urinary tract infection in post-menopausal women on vaginal estrogen with recurrent urinary tract infections.
What is the current status of trial NCT06598514?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 136 participants. The study started on 2024-12-23. Estimated completion is 2026-06.
What conditions does trial NCT06598514 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Recurrent Urinary Tract Infection.
What interventions are being tested in trial NCT06598514?
The interventions under investigation include: Chlorhexidine (DRUG), Sterile Water (DRUG).
Who is sponsoring clinical trial NCT06598514?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06598514 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NextGen - Clinical Implication of Next Generation Sequencing
RECRUITING · Phase 4
-
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
RECRUITING · Phase 1
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
RECRUITING
-
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.